Profil
Daniel Kaplan is currently the Chief Scientific Officer at NGM Biopharmaceuticals, Inc. He started this position in 2023.
Prior to his current role, he obtained a doctorate degree from Duke University and an undergraduate degree from the University of California San Diego.
Postes actifs de Daniel Kaplan
| Sociétés | Poste | Début |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2023 |
Formation de Daniel Kaplan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















